Global PARP Inhibitor Biomarkers Testing Product Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application

1.1 PARP Inhibitor Biomarkers Testing Product Product Overview

1.2 PARP Inhibitor Biomarkers Testing Product Market Segment by Type

1.2.1 Testing Kits

1.2.2 Testing Assays

1.3 Global PARP Inhibitor Biomarkers Testing Product Market Size by Type (2015-2026)

1.3.1 Global PARP Inhibitor Biomarkers Testing Product Market Size Overview by Type (2015-2026)

1.3.2 Global PARP Inhibitor Biomarkers Testing Product Historic Market Size Review by Type (2015-2020)

1.3.2.1 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share Breakdown by Type (2015-2026)

1.3.2.2 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share Breakdown by Type (2015-2026)

1.3.2.3 Global PARP Inhibitor Biomarkers Testing Product Average Selling Price (ASP) by Type (2015-2026)

1.3.3 Global PARP Inhibitor Biomarkers Testing Product Market Size Forecast by Type (2021-2026)

1.3.3.1 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share Breakdown by Application (2021-2026)

1.3.3.2 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share Breakdown by Application (2021-2026)

1.3.3.3 Global PARP Inhibitor Biomarkers Testing Product Average Selling Price (ASP) by Application (2021-2026)

1.4 Key Regions Market Size Segment by Type (2015-2020)

1.4.1 North America PARP Inhibitor Biomarkers Testing Product Sales Breakdown by Type (2015-2026)

1.4.2 Europe PARP Inhibitor Biomarkers Testing Product Sales Breakdown by Type (2015-2026)

1.4.3 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales Breakdown by Type (2015-2026)

1.4.4 Latin America PARP Inhibitor Biomarkers Testing Product Sales Breakdown by Type (2015-2026)

1.4.5 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales Breakdown by Type (2015-2026)

2 Global PARP Inhibitor Biomarkers Testing Product Market Competition by Company

2.1 Global Top Players by PARP Inhibitor Biomarkers Testing Product Sales (2015-2020)

2.2 Global Top Players by PARP Inhibitor Biomarkers Testing Product Revenue (2015-2020)

2.3 Global Top Players PARP Inhibitor Biomarkers Testing Product Average Selling Price (ASP) (2015-2020)

2.4 Global Top Manufacturers PARP Inhibitor Biomarkers Testing Product Manufacturing Base Distribution, Sales Area, Product Type

2.5 PARP Inhibitor Biomarkers Testing Product Market Competitive Situation and Trends

2.5.1 PARP Inhibitor Biomarkers Testing Product Market Concentration Rate (2015-2020)

2.5.2 Global 5 and 10 Largest Manufacturers by PARP Inhibitor Biomarkers Testing Product Sales and Revenue in 2019

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP Inhibitor Biomarkers Testing Product as of 2019)

2.7 Date of Key Manufacturers Enter into PARP Inhibitor Biomarkers Testing Product Market

2.8 Key Manufacturers PARP Inhibitor Biomarkers Testing Product Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Global PARP Inhibitor Biomarkers Testing Product Status and Outlook by Region (2015-2026)

3.1 Global PARP Inhibitor Biomarkers Testing Product Market Size and CAGR by Region: 2015 VS 2020 VS 2026

3.2 Global PARP Inhibitor Biomarkers Testing Product Market Size Market Share by Region (2015-2020)

3.2.1 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2015-2020)

3.2.2 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2015-2020)

3.2.3 Global PARP Inhibitor Biomarkers Testing Product Sales, Revenue, Price and Gross Margin (2015-2020)

3.3 Global PARP Inhibitor Biomarkers Testing Product Market Size Market Share by Region (2021-2026)

3.3.1 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2021-2026)

3.3.2 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2021-2026)

3.3.3 Global PARP Inhibitor Biomarkers Testing Product Sales, Revenue, Price and Gross Margin (2021-2026)

3.4 North America PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

3.4.1 North America PARP Inhibitor Biomarkers Testing Product Revenue YoY Growth (2015-2026)

3.4.2 North America PARP Inhibitor Biomarkers Testing Product Sales YoY Growth (2015-2026)

3.5 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

3.5.1 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue YoY Growth (2015-2026)

3.5.2 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales YoY Growth (2015-2026)

3.6 Europe PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

3.6.1 Europe PARP Inhibitor Biomarkers Testing Product Revenue YoY Growth (2015-2026)

3.6.2 Europe PARP Inhibitor Biomarkers Testing Product Sales YoY Growth (2015-2026)

3.7 Latin America PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

3.7.1 Latin America PARP Inhibitor Biomarkers Testing Product Revenue YoY Growth (2015-2026)

3.7.2 Latin America PARP Inhibitor Biomarkers Testing Product Sales YoY Growth (2015-2026)

3.8 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

3.8.1 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue YoY Growth (2015-2026)

3.8.2 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales YoY Growth (2015-2026)

4 Global PARP Inhibitor Biomarkers Testing Product by Application

4.1 PARP Inhibitor Biomarkers Testing Product Segment by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Others

4.2 Global PARP Inhibitor Biomarkers Testing Product Sales by Application: 2015 VS 2020 VS 2026

4.3 Global PARP Inhibitor Biomarkers Testing Product Historic Sales by Application (2015-2020)

4.4 Global PARP Inhibitor Biomarkers Testing Product Forecasted Sales by Application (2021-2026)

4.5 Key Regions PARP Inhibitor Biomarkers Testing Product Market Size by Application

4.5.1 North America PARP Inhibitor Biomarkers Testing Product by Application

4.5.2 Europe PARP Inhibitor Biomarkers Testing Product by Application

4.5.3 Asia-Pacific PARP Inhibitor Biomarkers Testing Product by Application

4.5.4 Latin America PARP Inhibitor Biomarkers Testing Product by Application

4.5.5 Middle East and Africa PARP Inhibitor Biomarkers Testing Product by Application

5 North America PARP Inhibitor Biomarkers Testing Product Market Size by Country (2015-2026)

5.1 North America Market Size Market Share by Country (2015-2020)

5.1.1 North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2015-2020)

5.1.2 North America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2015-2020)

5.2 North America Market Size Market Share by Country (2021-2026)

5.2.1 North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2021-2026)

5.2.2 North America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2021-2026)

5.3 North America Market Size YoY Growth by Country

5.3.1 U.S. PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

5.3.2 Canada PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

6 Europe PARP Inhibitor Biomarkers Testing Product Market Size by Country (2015-2026)

6.1 Europe Market Size Market Share by Country (2015-2020)

6.1.1 Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2015-2020)

6.1.2 Europe PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2015-2020)

6.2 Europe Market Size Market Share by Country (2021-2026)

6.2.1 Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2021-2026)

6.2.2 Europe PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2021-2026)

6.3 Europe Market Size YoY Growth by Country

6.3.1 Germany PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

6.3.2 France PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

6.3.3 U.K. PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

6.3.4 Italy PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

6.3.5 Russia PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Market Size by Country (2015-2026)

7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)

7.1.1 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2015-2020)

7.1.2 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2015-2020)

7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)

7.2.1 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2021-2026)

7.2.2 Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2021-2026)

7.3 Asia-Pacific Market Size YoY Growth by Country

7.3.1 China PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7.3.2 Japan PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7.3.3 South Korea PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7.3.4 India PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7.3.5 Australia PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7.3.6 Taiwan PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7.3.7 Indonesia PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7.3.8 Thailand PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7.3.9 Malaysia PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7.3.10 Philippines PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

7.3.11 Vietnam PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

8 Latin America PARP Inhibitor Biomarkers Testing Product Market Size by Country (2015-2026)

8.1 Latin America Market Size Market Share by Country (2015-2020)

8.1.1 Latin America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2015-2020)

8.1.2 Latin America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2015-2020)

8.2 Latin America Market Size Market Share by Country (2021-2026)

8.2.1 Latin America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2021-2026)

8.2.2 Latin America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2021-2026)

8.3 Latin America Market Size YoY Growth by Country

8.3.1 Mexico PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

8.3.2 Brazil PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

8.3.3 Argentina PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

9 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Size by Country (2015-2026)

9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)

9.1.1 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2015-2020)

9.1.2 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2015-2020)

9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)

9.2.1 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2021-2026)

9.2.2 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2021-2026)

9.3 Middle East and Africa Market Size YoY Growth by Country

9.3.1 Turkey PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

9.3.2 Saudi Arabia PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

9.3.3 UAE PARP Inhibitor Biomarkers Testing Product Market Size YoY Growth (2015-2026)

10 Company Profiles and Key Figures in PARP Inhibitor Biomarkers Testing Product Business

10.1 Myriad Genetics, Inc.

10.1.1 Myriad Genetics, Inc. Corporation Information

10.1.2 Myriad Genetics, Inc. Description, Business Overview and Total Revenue

10.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2015-2020)

10.1.4 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Products Offered

10.1.5 Myriad Genetics, Inc. Recent Development

10.2 Hoffmann-La Roche AG

10.2.1 Hoffmann-La Roche AG Corporation Information

10.2.2 Hoffmann-La Roche AG Description, Business Overview and Total Revenue

10.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2015-2020)

10.2.4 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Products Offered

10.2.5 Hoffmann-La Roche AG Recent Development

10.3 Invitae Corporation

10.3.1 Invitae Corporation Corporation Information

10.3.2 Invitae Corporation Description, Business Overview and Total Revenue

10.3.3 Invitae Corporation PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2015-2020)

10.3.4 Invitae Corporation PARP Inhibitor Biomarkers Testing Product Products Offered

10.3.5 Invitae Corporation Recent Development

10.4 NeoGenomics Laboratories, Inc.

10.4.1 NeoGenomics Laboratories, Inc. Corporation Information

10.4.2 NeoGenomics Laboratories, Inc. Description, Business Overview and Total Revenue

10.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2015-2020)

10.4.4 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Products Offered

10.4.5 NeoGenomics Laboratories, Inc. Recent Development

10.5 BPS Bioscience, Inc.

10.5.1 BPS Bioscience, Inc. Corporation Information

10.5.2 BPS Bioscience, Inc. Description, Business Overview and Total Revenue

10.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2015-2020)

10.5.4 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Products Offered

10.5.5 BPS Bioscience, Inc. Recent Development

...

11 PARP Inhibitor Biomarkers Testing Product Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 PARP Inhibitor Biomarkers Testing Product Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 PARP Inhibitor Biomarkers Testing Product Industrial Chain Analysis

11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis

11.4.1 Industry Trends

11.4.2 Market Drivers

11.4.3 Market Challenges

11.4.4 Porter’s Five Forces Analysis

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Distributors

12.3 Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Author Details

14.4 Disclaimer

Table 1. Major Company of Testing Kits

Table 2. Major Company of Testing Assays

Table 3. Global PARP Inhibitor Biomarkers Testing Product Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million)

Table 4. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Type (2015-2020) (K Units)

Table 5. Global PARP Inhibitor Biomarkers Testing Product Sales Share by Type (2015-2020)

Table 6. Global PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Type (2015-2020)

Table 7. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Type (2015-2020)

Table 8. Global PARP Inhibitor Biomarkers Testing Product Average Selling Price (ASP) (US$/Unit) by Type (2015-2020)

Table 9. Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2021-2026) (K Units)

Table 10. Global PARP Inhibitor Biomarkers Testing Product Sales Share by Type (2021-2026)

Table 11. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Type (2021-2026)

Table 12. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Type (2021-2026)

Table 13. Global PARP Inhibitor Biomarkers Testing Product Average Selling Price (ASP) (US$/Unit) by Type (2021-2026)

Table 14. North America PARP Inhibitor Biomarkers Testing Product Sales (US$/Unit) by Type (2015-2020)

Table 15. Europe PARP Inhibitor Biomarkers Testing Product Sales (US$/Unit) by Type (2015-2020)

Table 16. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales (US$/Unit) by Type (2015-2020)

Table 17. Latin America PARP Inhibitor Biomarkers Testing Product Sales (US$/Unit) by Type (2015-2020)

Table 18. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales (US$/Unit) by Type (2015-2020)

Table 19. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Company (2015-2020)

Table 20. Global PARP Inhibitor Biomarkers Testing Product Sales Share by Company (2015-2020)

Table 21. Global PARP Inhibitor Biomarkers Testing Product Revenue (Million US$) by Company (2015-2020)

Table 22. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Company (2015-2020)

Table 23. Global Market PARP Inhibitor Biomarkers Testing Product Average Selling Price (US$/Unit) by Company (2015-2020)

Table 24. Global PARP Inhibitor Biomarkers Testing Product Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 25. Global PARP Inhibitor Biomarkers Testing Product Top Manufacturers Product Category

Table 26. Global PARP Inhibitor Biomarkers Testing Product Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP Inhibitor Biomarkers Testing Product as of 2019

Table 28. Date of Key Manufacturers Enter into PARP Inhibitor Biomarkers Testing Product Market

Table 29. Key Manufacturers PARP Inhibitor Biomarkers Testing Product Product Type

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global PARP Inhibitor Biomarkers Testing Product Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026

Table 32. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Region (2015-2020)

Table 33. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2015-2020)

Table 34. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Region (2015-2020)

Table 35. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2015-2020)

Table 36. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 37. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Region (2021-2026)

Table 38. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2021-2026)

Table 39. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Region (2021-2026)

Table 40. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2021-2026)

Table 41. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 42. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application: 2015 VS 2020 VS 2026

Table 43. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2015-2020)

Table 44. Global PARP Inhibitor Biomarkers Testing Product Sales Share by Application (2015-2020)

Table 45. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2021-2026)

Table 46. Global PARP Inhibitor Biomarkers Testing Product Sales Share by Application (2021-2026)

Table 47. North America PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2015-2020)

Table 48. North America Sales PARP Inhibitor Biomarkers Testing Product Market Share by Application (2015-2020)

Table 49. Europe PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2015-2020)

Table 50. Europe Sales PARP Inhibitor Biomarkers Testing Product Market Share by Application In 2019

Table 51. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2015-2020)

Table 52. Asia-Pacific Sales PARP Inhibitor Biomarkers Testing Product Market Share by Application In 2019

Table 53. Latin America PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2015-2020)

Table 54. Latin America Sales PARP Inhibitor Biomarkers Testing Product Market Share by Application In 2019

Table 55. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2015-2020)

Table 56. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales Share by Application (2015-2020)

Table 57. North America PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Country (2015-2020)

Table 58. North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2015-2020)

Table 59. North America PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Country (2015-2020)

Table 60. North America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2015-2020)

Table 61. North America PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Country (2021-2026)

Table 62. North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2021-2026)

Table 63. North America PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Country (2021-2026)

Table 64. North America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2021-2026)

Table 65. Europe PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Country (2015-2020)

Table 66. Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2015-2020)

Table 67. Europe PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Country (2015-2020)

Table 68. Europe PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2015-2020)

Table 69. Europe PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Country (2021-2026)

Table 70. Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2021-2026)

Table 71. Europe PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Country (2021-2026)

Table 72. Europe PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2021-2026)

Table 73. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Region (2015-2020)

Table 74. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2015-2020)

Table 75. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Region (2015-2020)

Table 76. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2015-2020)

Table 77. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Region (2021-2026)

Table 78. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2021-2026)

Table 79. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Region (2021-2026)

Table 80. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2021-2026)

Table 81. Latin America PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Country (2015-2020)

Table 82. Latin America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2015-2020)

Table 83. Latin America PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Country (2015-2020)

Table 84. Latin America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2015-2020)

Table 85. Latin America PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Country (2021-2026)

Table 86. Latin America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2021-2026)

Table 87. Latin America PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Country (2021-2026)

Table 88. Latin America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2021-2026)

Table 89. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Country (2015-2020)

Table 90. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2015-2020)

Table 91. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Country (2015-2020)

Table 92. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2015-2020)

Table 93. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Country (2021-2026)

Table 94. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2021-2026)

Table 95. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Country (2021-2026)

Table 96. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2021-2026)

Table 97. Myriad Genetics, Inc. Corporation Information

Table 98. Myriad Genetics, Inc. Description and Business Overview

Table 99. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)

Table 100. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Product

Table 101. Myriad Genetics, Inc. Recent Development

Table 102. Hoffmann-La Roche AG Corporation Information

Table 103. Hoffmann-La Roche AG Description and Business Overview

Table 104. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)

Table 105. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Product

Table 106. Hoffmann-La Roche AG Recent Development

Table 107. Invitae Corporation Corporation Information

Table 108. Invitae Corporation Description and Business Overview

Table 109. Invitae Corporation PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)

Table 110. Invitae Corporation PARP Inhibitor Biomarkers Testing Product Product

Table 111. Invitae Corporation Recent Development

Table 112. NeoGenomics Laboratories, Inc. Corporation Information

Table 113. NeoGenomics Laboratories, Inc. Description and Business Overview

Table 114. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)

Table 115. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Product

Table 116. NeoGenomics Laboratories, Inc. Recent Development

Table 117. BPS Bioscience, Inc. Corporation Information

Table 118. BPS Bioscience, Inc. Description and Business Overview

Table 119. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)

Table 120. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Product

Table 121. BPS Bioscience, Inc. Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 125. Key Challenges

Table 126. Market Risks

Table 127. Distributors List

Table 128. PARP Inhibitor Biomarkers Testing Product Downstream Customers

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. PARP Inhibitor Biomarkers Testing Product Product Picture

Figure 2. Global PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) Status and Outlook (2015-2026)

Figure 3. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) Status and Outlook (2015-2026)

Figure 4. Product Picture of Testing Kits

Figure 5. Global Testing Kits Sales (K Units) and Growth Rate (2015-2020)

Figure 6. Product Picture of Testing Assays

Figure 7. Global Testing Assays Sales (K Units) and Growth Rate (2015-2020)

Figure 8. Global PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate by Type (US$ Million)

Figure 9. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2015-2020)

Figure 10. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type in 2019

Figure 11. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Type (2015-2020)

Figure 12. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type in 2019

Figure 13. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2021-2026)

Figure 14. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type In 2019

Figure 15. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Type (2021-2026)

Figure 16. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type In 2019

Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by PARP Inhibitor Biomarkers Testing Product Sales in 2019

Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by PARP Inhibitor Biomarkers Testing Product Revenue in 2019

Figure 19. PARP Inhibitor Biomarkers Testing Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 20. North America PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) and Growth Rate (2015-2026)

Figure 21. North America PARP Inhibitor Biomarkers Testing Product Sales YoY Growth (2015-2026) (K Units)

Figure 22. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) and Growth Rate (2015-2026)

Figure 23. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales YoY Growth (2015-2026) (K Units)

Figure 24. Europe PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) and Growth Rate (2015-2026)

Figure 25. Europe PARP Inhibitor Biomarkers Testing Product Sales YoY Growth (2015-2026) (K Units)

Figure 26. Latin America PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) and Growth Rate (2015-2026)

Figure 27. Latin America PARP Inhibitor Biomarkers Testing Product Sales YoY Growth (2015-2026) (K Units)

Figure 28. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) and Growth Rate (2015-2026)

Figure 29. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales YoY Growth (2015-2026) (K Units)

Figure 30. Hospital Examples

Figure 31. Clinic Examples

Figure 32. Others Examples

Figure 33. U.S. PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 34. U.S. PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 35. Canada PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 36. Canada PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 37. Germany PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 38. Germany PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 39. France PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 40. France PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 41. U.K. PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 42. U.K. PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 43. Italy PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 44. Italy PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 45. Russia PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 46. Russia PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 47. China PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 48. China PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 49. Japan PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 50. Japan PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 51. South Korea PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 52. South Korea PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 53. India PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 54. India PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 55. Australia PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 56. Australia PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 57. Taiwan PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 58. Taiwan PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 59. Indonesia PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 60. Indonesia PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 61. Thailand PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 62. Thailand PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 63. Malaysia PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 64. Malaysia PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 65. Philippines PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 66. Philippines PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 67. Vietnam PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 68. Vietnam PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 69. Mexico PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 70. Mexico PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 71. Brazil PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 72. Brazil PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 73. Argentina PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 74. Argentina PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 75. Turkey PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 76. Turkey PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 77. Saudi Arabia PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 78. Saudi Arabia PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 79. UAE PARP Inhibitor Biomarkers Testing Product Sales (K Units) (2015-2026)

Figure 80. UAE PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) (2015-2026)

Figure 81. Myriad Genetics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 82. Hoffmann-La Roche AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 83. Invitae Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 84. NeoGenomics Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 85. BPS Bioscience, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 86. Key Raw Materials Price

Figure 87. PARP Inhibitor Biomarkers Testing Product Manufacturing Cost Structure

Figure 88. PARP Inhibitor Biomarkers Testing Product Industrial Chain Analysis

Figure 89. Porter's Five Forces Analysis

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed